Clinical significance of nm23 gene expression in gastric cancer

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 3029-3033

  Mönig, Stefan P ^a   Nolden, Brit ^a   Lübke, Thomas ^a   Pohl, Alexandra ^a   Grass, Guido ^a   Schneider, Paul M ^a   Dienes, Hans P ^a   Hölscher, Arnulf H ^a   Baldus, Stephan E ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Gastric cancer; Immunohistochemistry; Lymph node metastasis; nm23

Indexed keywords

NM23 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTRECTOMY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; TUMOR DIFFERENTIATION; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 34547786168     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Siewert JR, Bottcher K, Stein HJ and Roder JD: Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228: 449-461, 1998.
2. Kojima T, Parra-Blanco A, Takahashi H and Fujita R: Outcome of endoscopic mucosal resection for early gastric cancer: review of the Japanese literature. Gastrointest Endosc 48: 550-554; discussion 554-555, 1998.
3. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y and Kitajima M: Radio-guided sentinel node detection for gastric cancer. Br J Surg 89: 604-608, 2002.
4. Bonenkamp JJ, Hermans, J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF and Tilanus H: Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908-914, 1999.
5. Monig SP, Zirbes TK, Schroder W, Baldus SE, Lindemann DG, Dienes HP and Holscher AH: Staging of gastric cancer: correlation of lymph node size and metastatic infiltration. Am J Roentgenol 173: 365-367, 1999.
6. Monig SP, Schroder W, Baldus SE and Holscher AH: Preoperative lymph-node staging in gastrointestinal cancer-correlation between size and tumor stage. Onkologie 25: 342-344, 2002.
7. Liotta L, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
8. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
9. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL Jr, Shows TB, Mathew S, Murty VV and Chaganti RS: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 8: 497-502, 1993.
10. Gilles AM, Presecan E, Vonica A and Lascu I: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 266: 8784-8789, 1991.
11. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445-449, 1991.
12. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Veron M, Strahler J and Hanash SM: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 89: 919-924, 1992.
13. Lakso M, Steeg PS and Westphal H: Embryonic expression of nm23 during mouse organogenesis. Cell Growth Differ 3: 873-879, 1992.
14. Kantor JD, McCormick B, Steeg PS and Zetter BR: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 53: 1971-1973, 1993.
15. Howlett AR, Petersen OW, Steeg PS and Bissell MJ: A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844, 1994.
16. Hartsough MT and Steeg PS: Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 32: 301-308, 2000.
17. Yoo CH, Noh SH, Kim H, Lee HY and Min JS: Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. J Surg Oncol 71: 22-28, 1999.
18. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
19. Hennessy C, Henry JA, May FE, Westley BR, Angus B and Lennard TW: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991.
20. Konishi N, Nakaoka S, Tsuzuki T, Matsumoto K, Kitahori Y, Hiasa Y, Urano T and Shiku H: Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Jpn J Cancer Res 84: 1050-1054, 1993.
21. Nakayama H, Yasui W, Yokozaki H and Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84: 184-190, 1993.
22. Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I and Takagi H: Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer 73: 259-265, 1994.
23. Hsu NY, Chow KC, Chen WJ, Lin CC, Chou FF and Chen CL: Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer. Clin Cancer Res 5: 1752-1757, 1999.
24. Muller W, Schneiders A, Hommel G and Gabbert HE: Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis. Cancer 83: 2481-2487, 1998.
25. Terada R, Yasutake T, Nakamura S, Hisamatsu T, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H and Tagawa Y: Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer. Med Oncol 19: 239-248, 2002.
26. Ura H, Denno R and Hirata K: The significance of nm23 protein expression in human gastric carcinomas. Surg Today 26: 957-965, 1996.
27. Chen JQ, Zhan WH, He YL, Peng JS, Wang JP, Cai SR and Ma JP: Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas. World J Gastroenterol 10: 776-782, 2004.
28. Liu YJ, Yan P S, Li J and Jia J F: Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. World J Gastroenterol 11: 6601-6606, 2005.
29. Kumar Dhar D, Kubota H, Tabara H, Kotoh T, Monden N, Igarashi M, Kohno H and Nagasue N: nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma. Oncology 56: 122-128, 1999.
30. Wang CS, Lin KH, Hsu YC and Hsueh S: Distant metastasis of gastric cancer is associated with elevated expression of the antimetastatic nm23 gene. Cancer Lett 128: 23-29, 1998.
31. Lee JH, Koh JT, Shin BA, Ahn KY, Roh JH, Kim YJ and Kim KK: Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer. Int J Oncol 18: 355-361, 2001.
32. Nesi G, Palli D, Pernice LM, Saieva C, Paglierani M, Kroning KC, Catarzi S, Rubio CA and Amorosi A: Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival. Anticancer Res 21: 3643-3649, 2001.
33. Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ and Kim JP: Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 33: 173-179, 2003.
34. Nakamura T, Tabuchi Y and Ohno M: Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions. Cancer Detect Prev 22: 246-250, 1998.